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Lipocalin-2 is a constituent of the neutrophil secondary granules and is expressed
de novo by macrophages and epithelium in response to inflammation. Lipocalin-2 acts
in a bacteriostatic fashion by binding iron-loaded siderophores required for bacterial
growth.Mycobacterium tuberculosis (M.tb) produces siderophores that can be bound by
lipocalin-2. The impact of lipocalin-2 in the innate immune response toward extracellular
bacteria has been established whereas the effect on intracellular bacteria, such as
M.tb, is less well-described. Here we show that lipocalin-2 surprisingly confers a growth
advantage on M.tb in the early stages of infection (3 weeks post-challenge). Using mixed
bone marrow chimeras, we demonstrate that lipocalin-2 derived from granulocytes, but
not from epithelia and macrophages, leads to increased susceptibility to M.tb infection.
In contrast, lipocalin-2 is not observed to promote mycobacterial growth at later stages
of M.tb infection. We demonstrate co-localization of granulocytes and mycobacteria
within the nascent granulomas at week 3 post-challenge, but not in the consolidated
granulomas at week 5. We hypothesize that neutrophil-derived lipocalin-2 acts to supply
a source of iron to M.tb in infected macrophages within the immature granuloma,
thereby facilitating mycobacterial growth.
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INTRODUCTION
Adaptive immunity against Mycobacterium tuberculosis (M.tb) is well-described, whereas the role
of the innate immune response that acts at the early stages of infection is not fully defined.
Lipocalin-2 is an innate immune protein, also known as neutrophil gelatinase-associated lipocalin
(NGAL), originally identified as a major constituent of the neutrophil secondary granules (1, 2).
In neutrophils, lipocalin-2 is produced exclusively at the myelocyte and metamyelocyte stages of
granulopoiesis in the bone marrow and stored in the secondary granules (3). Following the release
of neutrophils from bone marrow, lipocalin-2 can be exocytosed from the pre-formed granules.
Later, it has been recognized that lipocalin-2 can also be synthesized de novo by epithelial cells and
macrophages in response to inflammatory stimuli (4–7). In mice (8, 9), but not in humans (10),
lipocalin-2 is also produced in the liver as an acute phase-protein.
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The best described function of lipocalin-2 is the capacity
to prevent growth and spread of microorganisms that require
siderophore-mediated uptake of iron (11). Siderophores are
produced by a range of microorganisms, including M.tb (12),
and bind ferric iron with high affinity by scavenging the host’s
iron deposits (13). Lipocalin-2 forms a ternary structure with
the siderophore preventing bacterial uptake of siderophore-
bound iron thus acting bacteriostatically (11). Lipocalin-2 knock-
out mice (Lcn2−/− mice) are more susceptible to infection by
siderophore-producing pathogens, such as Klebsiella pneumonia
(14, 15) and Escherichia coli (16, 17).
Pathogenic mycobacteria produce two types of siderophores
that can be bound by lipocalin-2: mycobactin, an envelope-
restricted siderophore, and the water soluble carboxymycobactin.
Both siderophores bind Fe3+ with high affinity and sequester
soluble as well as protein-bound iron (18–20). Only a few studies
have investigated the in vivo role of lipocalin-2 in mycobacterial
infection models (21–23) and the focus has been on the role
of lipocalin-2 at late time points following infection when the
adaptive immune response is activated and mature granulomas
have been formed. However, since lipocalin-2 is produced in cells
that are primarily active in the early innate immune response,
we wanted to address the role of lipocalin-2 in control of
M.tb infection before the transition of the local inflammatory
environment to an adaptive immune response associated with
recruitment of antigen-specific T cells. Furthermore, we wanted
to elucidate whether the cellular origin of lipocalin-2 is important
for infection control by establishing a chimeric bone marrow
model that would allow us to discriminate myeloid cell-derived
lipocalin-2 from epithelia cell-derived lipocalin-2. In this study,
we report for the first time that lipocalin-2 promote M.tb
replication early in infection. Moreover, we find that the cellular
origin of lipocalin-2 is important in M.tb infection, since only
neutrophil-derived lipocalin-2 is associated with an increased
susceptibility to M.tb infection in this model. The increased
susceptibility to M.tb infection mediated by neutrophil-derived
lipocalin-2 could be related to the close proximity of neutrophils
and M.tb within the immature granuloma.
METHODS
Mice
B6.Lcn2−/– mice (16) and C57BL/6NTac wildtype (WT)
mice were bred at Taconic, Denmark. Congenic B6.SJL-
PtprcaPepcb/BoyCrl (SJL.WT) wildtype mice, used in the
transplantation setup, were bred at Charles River’s facility in Italy.
All mice were bred in opportunist-free barriers. M.tb infected
mice were housed in a biosafety level III facility in ventilated
cages with laminar air flow and with water and food ad libitum.
All mice used in the experiments were females between 8 and 12
weeks old.
Bone Marrow Transplantation
The congenic CD45 (Ly-5) mouse system was employed
wherein SJL.WT mice expressing the CD45.1 variant of the
leukocyte surface marker CD45, and WT and Lcn2−/– mice
expressing the CD45.2 variant, were used in the transplantation
experiment. Mice were lethally irradiated with 900 cGy followed
by transplantation with bone marrow cells from donor mice
by intravenously injection into the tail vein of recipient mice 1
day after lethal irradiation. All recipients received 5 × 106 bone
marrow cells. Mice were housed in individually ventilated cages
and handled under restricted hygienic conditions. Ciprofloxacin
(Actavis, 100mg/L) was added to their drinking water for the first
21 days. Seven weeks post-transplantation neutrophil chimerism
was determined on jaw vein blood from all mice included in the
transplantation setup. Macrophage chimerism was evaluated in
a pilot study on bronchoalveolar lavage (BAL fluid). Antibodies
used for determining chimerism were: Rat anti-mouse Gr-1 APC
(1:300, clone RB6-8C5, BioLegend), rat anti-mouse F4/80 (1:100,
clone BM8, BioLegend) and mouse anti mouse CD45.1 PE (1:50,
clone A20, eBioscience), and CD45.2 FITC (1:200, clone 104,
BD).
Mycobacterial Infection
For all experiments M.tb strain H37Rv was used. H37Rv was
grown in Middlebrook 7H9 broth with glycerol (BD, 221832)
supplemented with ADC enrichment (BD, 211887). Mid log
phase cultures were aliquoted and stored at−80◦C.
Mice were challenged with M.tb H37Rv using Biaera AeroMP
system. Briefly, an H37Rv aliquot was thawed and the suspension
sonicated for 5min in a water-bath and drawn three times
through a 27 gauge needle to ensure a proper dispersion of
mycobacteria. Mycobacteria were diluted in 15ml phosphate-
buffered saline and delivered by aerosol route ∼1,000 colony
forming units (CFU) per mouse (as determined by total lung
CFU 1 day after challenge). Aerosol suspensions were serially
diluted and plated to confirm consistent exposure between
experiments.
Mice were sacrificed at the time points indicated in the
individual experiments subsequent to scoring on a scale from 0 to
5 based on the following clinical criteria: 0: Mouse is unaffected,
1: Mouse is slightly affected (e.g., slight piloerection or slightly
commencing waistline), 2: Mouse is affected (e.g., piloerection,
commencing waistline, and slightly decreased mobility), 3: The
mouse is obviously affected (e.g., closed eyes, marked waistline,
hunch-backed posture, affected breathing, decreased mobility),
4: Mouse is severely affected and should be euthanized, 5: The
mouse is dead.
Mice were sedated with Isoflourane (Baxter) for whole blood
collection from the orbital sinus in EDTA coated tubes and
followed by aseptical removal of lung, spleen, and liver.
Colony-Forming Units and Isolation of
Cells From the Lung
To determine bacterial load, total left lungs were homogenized
in MQ+ MGITTM PANTATM (BD, 245114) in Gentle MACS
M-tubes and plated in 3-fold serial dilution on 7H11 agar
(BD, 221870). After 3 weeks of incubation at 37◦C, CFU were
enumerated.
Lung cells were isolated by digesting total lung in
Collagenase VIII (C2139, Sigma) for 30min. followed by
gentle homogenization in Gentle MACS C-tube. Homogenate
was forced through 70µm cell strainer (BD Pharmigen) and
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incubated in ammonium chloride solution for 5min to lyse red
blood cells. Cells were washed × 2 and resuspended in RPMI +
10% FCS, followed by flow cytometry analysis.
ELISA
For optimal protein extraction, total left lung homogenate
(prepared as described above) was added to 5 × RIPA
buffer with protease inhibitors, incubated on ice for 30min.
and centrifuged. Supernatant was collected and ELISA was
performed. Quantification of plasma and lung lipocalin-2
was executed by standard ELISA techniques (10, 24). The
following antibodies was used: Affinity-purified goat anti-
lipocalin-2 (1:500, AF 1857, R&D Systems), biotinylated
rabbit anti-lipocalin-2 [1:200, in-house-generated antibody
(10)], and horseradish peroxidase Avidin D (1:3,000, 18–
4,100, eBioscience). As a surrogate marker of neutrophil
influx myeloperoxidase, (MPO) ELISA (ab155458, Abcam) was
performed according to manufacturer’s instructions.
RNA and Quantitative Real Time PCR
Right lung lobes and the largest liver lobes were removed
and quickly stored in RNA Later (Thermo Fischer Scientific).
Organs were homogenized in TRIzol Reagent (Invitrogen) in
Gentle MACS M-tubes, and RNA purification was performed
according to the manufacturer’s instructions. mRNA expression
was evaluated by quantitative real-time PCR (qRT-PCR) using
the TaqMan system (Applied Biosystems). All samples were
analyzed in triplicate. Expression levels of Actb and Gapdh
housekeeping genes were used for internal normalization.
Relative gene expression was calculated by the comparative
threshold method (25) (2−11Ct) and is presented as “fold
change of expression” compared to uninfected controls. Results
were analyzed using MxPro software (Stratagene). HEX-labeled
probes were used for quantification of the internal normalization
controls Actb (4352341E) and Gapdh (435339E). FAM-labeled
probes were used for quantification of Lcn2: Mm01324470_m1,
Tfrc: Mm00441941_m1, Fth1: Mm00850707_g1, Slc11a1:
Mm00443045_m1, Slc11a2: Mm00435363_m1, Slc40a1:
Mm0125482, Bdh2: Mm00459075_m1, Lrp2: Mm01328171_m1,
Slc22a17: Mm00480680_m1, Cxcl1: Mm04207460_m1,
Cxcl2: Mm00436450_m1, Ccl5: Mm01302427_m1, Cxcl9:
Mm00434946_m1, and Cxcl10: Mm00445235_m1. All probes
were purchased from Applied Biosystems.
Multiplex Cytokine Assay
Bead-based Mouse Magnetic Luminex assay (R&D systems)
was performed according to manufacturer’s instructions and
analyzed by Luminex 200 system. The following cytokines were
measured: G-CSF, TNF-α, INF-γ, KC, IL-1β, and MIP2 in total
lung homogenate supernatant.
Flow Cytometry
Total B-cell, T-cell, and neutrophil cell counts were estimated by
flow cytometry on total lung homogenate 3 and 5 weeks post-
challenge using anti-Ly6G APC (clone 1A8, Biolegend), anti-
CD11b PE (clone M1/79, Biolegend), anti-CD11c PerCP-Cy5.5
(clone HL3, BD), anti-CD19 APC (clone 1D3, BD), anti-CD4
FITC (clone RM4-5, BD), and anti-CD8 PE (clone 53-6.7, BD).
All antibodies were diluted 1:200 frommanufacturer stocks. Flow
cytometry was performed on BD Accuri C6 and analyzed with
FlowJo 10.0.8 software (Tree Star Inc).
Histopathological Analysis
Total lung and heart was removed en bloc. Before removal,
trachea was catheterized and 1.5ml of 10% formalin was installed
to expand the lungs. In addition, spleen and liver were removed.
Organs were fixated in 10% neutral buffered formalin for 24 h and
stored in 70% ethanol. Paraffin embedded 5µm thick sections
were stained Ziehl-Neelsen (ZN) and eosin-hematoxylin (H&E).
Immunohistochemically staining for lipocalin-2 was
performed on lung sections. Sections were deparaffinized
and hydrated. To make epitopes accessible for antibodies,
sections were pretreated with proteinase K for 15min. at 37◦C.
Endogen peroxidase was blocked with 1% H2O2. Sections
were incubated with 5% rabbit serum for 30min followed by
overnight incubation at 4◦C with primary antibody, goat anti
mouse lipocalin-2 (1:3,200 AF1857, R&D). Day 2 samples were
incubated for 45min with secondary antibody, rabbit anti
FIGURE 1 | Expression of lipocalin-2 as a function of time after aerosol challenge with M.tb H37Rv. (A) Expression of Lcn2 mRNA in lungs 3 and 5 weeks
post-challenge analyzed by qRT-PCR using GAPDH as internal control and presented as fold change (2−11Ct). (B,C) Lipocalin-2 concentration in lung homogenates
(B) and plasma (C) at 3 and 5 weeks post-challenge. Error bars (A) indicate standard deviations and horizontal bars (B,C) indicate means. The dotted line indicates
mean for uninfected controls. **p < 0.01, ***p < 0.001, and ****p < 0.0001 by ANOVA with Tukey’s multiple comparison test.
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goat-HRP (P0449, Dako), and developed with DAB+ (DAB+
Envisions-System K5007, Dako) and counter stained with
Mayer’s hematoxylin.
Validation of the data was made by two independent
pathologists, both blinded of the treatment groups. A semi-
quantitative scoring system was used for evaluating the staining
results. The slides were scanned using VisionTek digital
microscope (Sakura Finetek).
Statistical Analysis
All statistical calculations were performed using GraphPad Prism
(GraphPad software v.7.2). CFU, ELISA data, cytokine data,
and total cell counts were log-transformed before analysis.
Normality was evaluated for group residuals and requirements
for parametric analysis were met. Comparison of two groups
was performed by students T-test with Welch correction, and
comparison of more than two groups was performed by one-way
ANOVA and Tukey’s multiple comparison post-test. When two
variables were evaluated (time and genotype), two-way ANOVA
with Sidák-Holm post-test was used. Our RT-qPCR data was
analyzed by one-way ANOVA applied on 1Ct values. Clinical
scores between subgroups were analyzed for determination of
dependency with χ2-test. Only statistically significant results
are depicted on the graphs. P ≤ 0.05 was considered
significant.
RESULTS
Lipocalin-2 Competent Mice Show
Increased Susceptibility to M.tb Infection
at 3 Weeks Post-challenge
It has previously been reported that lipocalin-2 is important
for control of M.tb during the chronic stage of infection (21).
To evaluate the lipocalin-2 expression pattern following M.tb
infection, Lcn2 gene expression was measured in the lungs
of WT mice during the growth/primary stage (3 weeks) and
the post-peak chronic stage (5 weeks) after aerosol-infection
with M.tb relative to that of uninfected WT mice. At 3 weeks
post-challenge, we found a 6.6-fold induction of lung Lcn2
mRNA compared to baseline expression in uninfected mice
(Figure 1A). Five weeks post-challenge the lung Lcn2 mRNA
level was still higher, although slightly decreased (3.7-fold
higher than in uninfected mice). Similarly, high amounts of
lipocalin-2 protein were observed in lungs at 3 and 5 weeks
compared to uninfected mice (Figure 1B). The same pattern of
lipocalin-2 expression was observed in plasma of the same mice
(Figure 1C).
High expression of lipocalin-2 was observed at week 3,
when formation of lung granulomas is in its early phase. For
this reason, we decided to use Lcn2−/− mice to examine the
importance of lipocalin-2 at this stage where control of M.tb
infection is exerted primarily by the innate immune system. To
our surprise we observed a nearly 2-fold higher infection burden
(CFU, colony-forming units) in lungs of WT mice 3 weeks
post-challenge compared to mice unable to produce lipocalin-2
(Figure 2A). At 5 weeks, lung CFU were comparable between
FIGURE 2 | Lack of Lcn2 expression causes higher infection burden 3 weeks
after aerosol challenge with M.tb H37Rv. (A) Bacterial load per lung in mice
with M.tb H37Rv shown as colony-forming units (CFU) (n = 13–16 per group).
(B) MPO concentrations measured by ELISA in total lung homogenate (n =
7–8 per group). (C) Total number of Ly6G+, CD11b+ neutrophils isolated from
lung measured by flow cytometry (n = 5–8 per group). Horizontal bars indicate
mean. The dotted line indicates mean for uninfected controls. ***p < 0.001,
****p < 0.0001 by student’s T-test or two-way ANOVA with Sidaks’s multiple
comparison test.
WT and Lcn2−/−. However, when comparing bacterial load in
the lungs over time, the bacterial load was reduced in theWT but
continuously elevated in the Lcn2−/− mice, indicating reduced
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FIGURE 3 | Expression profile in lung 3 and 5 weeks after aerosol challenge with M.tb H37Rv. Relative expression of chemokine mRNAs in lung related to adaptive
immune response: (A) Cxcl9, (B) Ccxl10, and (C) Ccl5 and innate immune response: (D) Cxcl1 and (E) Cxcl2. Expression was analyzed by qRT-PCR with β-actin as
internal control and normalized to uninfected controls and presented as fold change (2−11Ct). (n = 7–8 animals in each group). Error bars indicate standard
deviations. *p < 0.05, **p < 0.01, and ***p < 0.001, ****p < 0.0001 by student’s T-test or two-way ANOVA with Sidaks’s multiple comparison test.
capability of the Lcn2−/− mice in controlling M.tb infection
(Figure 2A). The 10-fold lower numbers of mycobacteria in WT
mice at week 5 compared to week 3 indicates that WT mice were
able to contain the M.tb infection to a level similar to that of
Lcn2−/− mice.
Increased Susceptibility to M.tb Infection
in Lipocalin-2 Competent Mice Is Not
Related to Changes in the Inflammatory
Cytokine Response
To determine whether disparities in CFU in the lung were a
consequence of differences in neutrophil influx we measured
the amount of myeloperoxidase (MPO) in lung lysates. MPO
is stored in the primary granules of the neutrophil and is thus
a biomarker of the amount of neutrophils in the lungs. No
difference in MPO was observed between the two genotypes at
either time point (Figure 2B). In addition, we compared the
total number of neutrophils in lung tissue by flow cytometry
and found no differences in total Ly6G+, CD11b+ cell count
between the two genotypes (Figure 2C). These data suggest
that the observed differences in mycobacterial loads in the
lung were not due to differences in the recruitment of lung
neutrophils.
We wished to examine whether differences in expression
of inflammatory response genes that are related to control
of M.tb infection (26) could explain the differences in lung
CFU between WT and Lcn2−/− mice at 3 and 5 weeks post-
infection. Cxcl9 and Cxcl10 are gamma-interferon induced
genes encoding T-cell, NK-cell, and monocyte/macrophage
chemoattractants. No major differences were observed in Cxcl9
and Cxcl10 transcript levels in lungs between genotypes at 3
or 5 weeks (Figures 3A,B). Ccl5 (RANTES), encoding another
important T-cell activator and chemoattractant, also showed no
differences in transcript levels between genotypes (Figure 3C).
However, a significant increase in Cxcl9 and Ccl5 transcript
levels was observed from week 3 to 5 for both genotypes,
indicating a mechanism for enhanced recruitment of effector
cells related to an adaptive immune response at week 5.
Cxcl1 and Cxcl2 both encode neutrophil chemoattractants. WT
mice had increased Cxcl1 expression at 3 weeks compared to
Lcn2−/− mice and Cxcl2 transcript also tended to be higher
in WT mice, however the difference in Cxcl2 transcript levels
between WT and Lcn2−/− mice was not significant (Figure 3D).
This indicates that WT mice have increased expression of
neutrophil chemoattractant at 3 weeks, which might reflect
the increased infection burden in the WT mice at this time
point. Conversely, the transcript level of Cxcl2 was significantly
downregulated in WT mice at week 5 compared to week
3, indicating a shift from an innate to an adaptive immune
response and better infection control (Figure 3E). This pattern
did not apply to Lcn2−/− mice, where the Cxcl2 mRNA
levels are unaltered indicating lack of infection control at
week 5 compared to WT (Figure 3E). Furthermore, the total
number of CD4+, CD8+, and CD19+ cells within the infected
lung indicated no difference in the capacity to initiate the
adaptive immune response between the two genotypes (data not
shown).
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FIGURE 4 | Lipocalin-2 expression profile and CFU in lungs day 0–14 after
challenge with M.tb. Lcn2−/− mice reconstituted with WT bone marrow
(KO/WT) and WT mice reconstituted with Lcn2−/− bone marrow (WT/KO)
were challenged with M.tb strain H37Rv by aerosol route and euthanized 2, 4,
7, and 14 days post-challenge (n = 3–4 in each subgroup). (A) Relative
expression of Lcn2 in total lung homogenate analyzed by qRT-PCR with
GAPDH as internal control and normalized to uninfected control and presented
as fold change (2−11Ct). (B) Lipocalin-2 concentrations in total lung
homogenate measured by ELISA. (C) Bacterial load per lung in the two
chimeric subgroups shown as CFU. (B,C) The boxes indicate the rages of the
observations and the horizontal bars indicate mean. Dotted line indicates level
for uninfected mice. ***p < 0.001, ****p < 0.0001 by students T-test or
two-way ANOVA with Sidaks’s multiple comparison test. Error bars indicate
standard deviations.
Lipocalin-2 Expression in Early M.tb
Infection
Next, we evaluated differences in lipocalin-2 expression and
production from the different lipocalin-2-producing cellular
compartments, i.e., macrophages/neutrophils and epithelia, in
the very early phase of M.tb infection. To this end, chimeric mice
were generated by lethally irradiating WT, SJL.WT and Lcn2−/−
mice followed by transplantation with bone marrow cells from
SJL.WT or Lcn2−/− mice. Neutrophils and macrophages are the
two main hematopoietic cell subtypes that produce lipocalin-2.
Neutrophil chimerism in the blood was determined individually
for each mouse 7 weeks post-transplantation and was found
to be 97–100% donor derived (Supplementary Figure 1).
Macrophage chimerism was determined in a pilot experiment
by evaluation of BAL fluid 7 weeks post-transplantation and
demonstrated 96–99% of all F4/80+ macrophages to be donor-
derived (data not shown). The chimeric expression pattern of
lipocalin-2 was confirmed by immunohistochemically staining
(Supplementary Figure 2).
Lcn2−/− recipient mice reconstituted with SJL.WT bone
marrow (KO/WT) and SJL.WT recipient mice reconstituted with
Lcn2−/− bone marrow (WT/KO), respectively, were challenged
with M.tb strain H37Rv through the aerosol route of infection
and euthanized 2, 4, 7, and 14 days after infection. Assessment
of Lcn2 transcript and lipocalin-2 protein levels was performed
on lung homogenates at the different time points (Figures 4A,B).
Lcn2 transcript in lungs of KO/WT mice was expressed at lower
levels than in uninfected WT controls (relative expression = 1)
at all time points reflecting the inability of these mice to express
Lcn2 in lung epithelium. For WT/KO mice Lcn2 expression was
comparable to that of uninfectedWTmice at days 2, 4, and 7 and
increased to an almost 3-fold higher expression level at day 14
post-challenge (Figure 4A).
Lipocalin-2 protein levels in the lung of WT/KO mice were
significantly lower at all infection time points compared to
uninfected WT controls, demonstrating that the baseline protein
level must originate predominantly from circulating neutrophils
(Figure 4B). When comparing relative lipocalin-2 levels at the
different time points, we saw an increase at day 14, indicating that
the contribution of lipocalin-2 from the epithelium is initiated
at this time point. Lipocalin-2 levels in the KO/WT mice were
comparable to uninfected mice at all time points, illustrating
that there is no major contribution of lipocalin-2 from the
myeloid population the first 14 days of infection (Figure 4B).
Bacterial burden in lungs of the chimeric mice were determined
to establish when the differences between genotypes arise during
infection. There were no differences in lung CFU between the
chimeric groups at these early time-points, with progression of
lung infection occurring between day 7 and 14 for both chimeric
groups (Figure 4C).
Lcn2 expression in the liver was also analyzed at the same time
points. KO/WT mice had lower expression than uninfected WT
controls, while in WT/KO mice the level of Lcn2 expression was
equal to that in uninfectedWT controls demonstrating that there
was no acute phase response at these early time points (data not
shown).
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FIGURE 5 | Lipocalin-2 derived from the myeloid compartment is associated with increased susceptibility to M.tb 3 weeks after infection. WT mice reconstituted with
WT bone marrow (WT/WT, n = 12), Lcn2−/− mice reconstituted with WT bone marrow (KO/WT, n = 11), WT mice reconstituted with Lcn2−/− bone marrow (WT/KO,
n = 10), and Lcn2−/− mice reconstituted with Lcn2−/− bone marrow (KO/KO, n = 10) were challenged with M.tb strain H37Rv by aerosol route and euthanized 3
weeks post-challenge. (A) End weight in grams. (B) Clinical severity score of the four chimeric subgroups 3 weeks after challenge (each of the subgroups comprises
100% and the percentage of mice with a specific score is presented by different patterns within the 100%). (C,D) Bacterial load per lung (C) and spleen (D) in the four
chimeric subgroups shown as CFU. (E) Lipocalin-2 concentrations in total lung homogenate measured by ELISA. (F) Relative expression of Lcn2 in total lung
homogenate analyzed by qRT-PCR with GAPDH as internal control and normalized to uninfected control and presented as fold change (2−11Ct). Horizontal bars
indicate mean. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by ANOVA with Tukey’s multiple comparison test. Error bars indicate standard deviations.
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FIGURE 6 | Lipocalin-2 in granulocytes is associated with increased levels of pro-inflammatory cytokines and chemokines in lung. (A) Keratinocyte chemoattractant
CXCL1 (KC), (B) Macrophage inflammatory protein CXCL2 (MIP2). (C) Granulocyte colony-stimulating factor (G-CSF), (D) Interleukine 1-β (IL-1β), (E) Interferon-γ
(INF-γ), and (F) Tumor necrosis factor-α (TNF-α) protein levels in lung homogenate, from bone marrow transplanted mice 3 weeks post-challenge with M.tb. Horizontal
bars indicate mean. *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001 by ANOVA with Tukey’s multiple comparison test. Error bars indicate standard deviations.
To determine the time of neutrophil influx in lungs, MPO
ELISA on lung homogenates was performed. MPO levels were
the same as measured in uninfected controls for all time points,
indicating that substantial neutrophil migration occurs later than
day 14 post-challenge, concomitant with the increase of lung
bacterial burden (data not shown). From this we conclude that
lipocalin-2 does not play a role in the progress of M.tb infection
at time points earlier than day 14 post-challenge.
Only Neutrophil-Derived Lipocalin-2 Leads
to Increased Susceptibility to M.tb
Since lipocalin-2 is released by different cell types present in the
infected lung [neutrophils, macrophages, and epithelia cells of the
bronchus including alveolar type II pneumocytes (2, 7, 21, 27)]
we wanted to explore whether the increased susceptibility toM.tb
infection in WT mice at 3 weeks post-challenge was dependent
on the origin and location of the produced lipocalin-2. Chimeric
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FIGURE 7 | Quantification of transcripts for proteins involved in iron homeostasis in lungs 3 and 5 weeks after aerosol challenge with M.tb H37Rv. Expression of
mRNAs related to iron homeostasis in the lung relative to uninfected controls. (A) Transferrin receptor (Tfrc), (B) Ferroportin (Slc40a1), (C) DMT1 (Slc11a2), (D)
NRAMP1 (Slc11a1), (E) Ferritin (Fth1), (F) 24p3-R (Slc22a17), (G) Megalin-R (Lrp2), and (H) 2,5-DBHA (Bdh2). Expression was determined by qRT-PCR with β-actin
(Tfrc, Slc40a1, Slc11a1, Slc11a2, Fth1) or GAPDH (Slc22a17, Lrp2, Bdh2) as internal controls and normalized to uninfected controls and presented as fold change
(2−11Ct). (n ≥ 7 animals per group). *p < 0.05, **p < 0.01 ***p < 0.001 and ****p < 0.0001 by students T-test or two-way ANOVA with Sidak’s multiple comparison
test. Error bars indicate standard deviations.
mice were challenged with M.tb strain H37Rv by aerosol route
of infection 9 weeks post-transplant and assessed 3 weeks post-
challenge. This time point was chosen for evaluation of the
infected chimeric mice based on the results from the lipocalin-
2 expression experiment (Figure 4) where difference in outcome
between Lcn2−/− and WT occurs between week 2 and 3.
WT recipient mice reconstituted with SJL.WT bone marrow
(WT/WT) and Lcn2−/− recipient mice reconstituted with
SJL.WT bone marrow (KO/WT) showed increased disease
progression by clinical evaluation and significant weight
loss, compared to SJL.WT recipient mice reconstituted with
Lcn2−/− bone marrow (WT/KO) and Lcn2−/− recipient
mice reconstituted with Lcn2−/− bone marrow (KO/KO)
(Figures 5A,B). The same pattern was observed when comparing
lung CFU between the different chimeric subgroups. Both the
WT/WT mice and the KO/WT mice had significantly higher
bacterial loads in lungs compared to WT/KO and KO/KO
mice (Figure 5C). No differences in spleen CFU were seen
between groups (Figure 5D). Since there were no differences
in clinical score, weight loss, or lung CFU between the
WT/WT and KO/WT mice, we conclude that lipocalin-2 from
neutrophils and/or macrophages is responsible for the increased
susceptibility to M.tb 3 weeks post-challenge and that lipocalin-2
derived from epithelial cells has little importance on outcome.
To further investigate the contribution of lipocalin-2 from the
different cellular compartments, i.e., macrophages/neutrophils
vs. epithelia, we determined the levels of lipocalin-2 in
total lungs of the three chimeric subgroups capable of
Lcn2 expression (Figure 5E). As expected, the amount
of lipocalin-2 was highest in the WT/WT mice, but
lipocalin-2 from neutrophils and macrophages (KO/WT)
as well as lipocalin-2 produced by lung epithelial cells
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FIGURE 8 | Histopathological features of granulomas in lungs of WT and Lcn2−/− mice 3 and 5 weeks after aerosol challenge with M.tb H37Rv. Representative ZN
and HE-stained lung tissue from WT mouse 3 and 5 weeks post-challenge with M.tb. Black arrows indicate ZN positive rods and red arrows indicates neutrophils.
(WT/KO) both contributed to the total amount of lung
lipocalin-2.
The increased weight loss, clinical score, and higher lung CFU
in the WT/WT and KO/WT suggests that macrophage- and/or
neutrophil-derived lipocalin-2 increases susceptibility to M.tb
infection 3 weeks after challenge. To investigate whether it was
mainly macrophages or neutrophils that contributed to lipocalin-
2 in the lung, we performed qRT-PCR on lung homogenate
from the chimeric mice (Figure 5F). Lipocalin-2 in neutrophils is
exclusively produced during maturation of neutrophil precursors
in the bone marrow, so any detected mRNA in the lung will
originate from either epithelia or macrophages. The expression
of Lcn2mRNA in the lungs of KO/WTmice (where any detected
Lcn2 mRNA derives only from macrophages) was slightly lower
than uninfected controls, whereas the Lcn2 transcript levels in
WT/KO mice (where Lcn2 mRNA only represents expression
by epithelia) was significantly upregulated demonstrating that
Lcn2 expression from macrophages is negligible under these
settings.
To assess whether the inflammatory response differed between
the four chimeric subgroups we measured the levels of
the neutrophil chemoattractants Cxcl1, Cxcl2, and G-CSF in
lung homogenates by multiplex cytokine assay (Luminex). No
difference in cytokine levels was observed between WT/WT
and KO/WT mice, which both showed a consistent pattern
of higher expression levels compared to that in lungs of
WT/KO and KO/KO mice (Figures 6A–C). This probably
reflects the increased clinical score and higher bacterial burden
in WT/WT and KO/WT mice and consequently a more intense
inflammatory response. The same pattern of expression was
observed for the pro-inflammatory cytokines IL-1β, TNF-α, and
IFN-gamma in the four chimeric groups (Figures 6D–F). The
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increased Cxcl1 and Cxcl2 protein levels in the WT/WT and
KO/WT mice corresponds to the observations in Figures 3D,E
where WT mice were found to have increased mRNA expression
of these two cytokines.
Evaluation of Iron Metabolism Reveals
Downregulation of Lipocalin-2 Receptors
Lipocalin-2 has previously been proposed to play a role in
iron homeostasis (28) and we speculated whether the growth-
promoting effect of lipocalin-2 at 3 weeks after infections was
related to changes in iron metabolism. If release of lipocalin-
2 from neutrophils during the earlier stages of M.tb infection
(i.e., 3 weeks) could lead to increased accessibility of iron to
the infected macrophages, then this could explain the advantage
of lacking the lipocalin-2 at this time point. To test this, we
quantified the relative expression levels of several genes related
to iron homeostasis on total lung homogenate from Lcn2−/− and
WT mice 3 and 5 weeks post-M.tb challenge.
Expression of transporters of iron across the cell membrane,
transferrin-receptor, ferroportin, and DMT1, were only slightly
upregulated compared to uninfected controls (Figures 7A–C).
However, transcript levels of transferrin-receptor were
higher in Lcn2−/− mice at both time-points. NRAMP1 is
a phagolysosome-bound protein that pumps iron from the
phagocytic vacuole into the surrounding cytosol. There were no
differences in expression of NRAMP1 betweenWT and Lcn2−/−
mice at the two time-points, but the overall expression was about
10 times higher in infected animals than in uninfected controls
at 3 weeks and 15–20 times higher at 5 weeks (Figure 7D).
Transcript levels of ferritin were also comparable between
genotypes and upregulated 5 weeks post-challenge compared
to 3 weeks (Figure 7E). With regard to genes specifically
related to lipocalin-2 metabolism, we examined the transcript
levels for the two known receptors for lipocalin-2, 24p3-R and
megalin (29, 30), which mediate transport of the protein and
its bound iron-loaded siderophore into the cell. Transcript
levels of 24p3-R in Lcn2−/−-mice were slightly higher at 3
weeks compared to WT (Figures 7F,G). Interestingly, however,
both receptors were significantly downregulated compared to
uninfected WT controls. Furthermore, we also looked at the
proposed mammalian siderophore 2,5-DHBA, suggested to
be a ligand for lipocalin-2 and related to iron homeostasis.
Expression of the gene encoding 2,5-DHBA was higher at 3
weeks in the Lcn2−/− mice, but also significantly downregulated
compared to uninfected controls (Figure 7H). Although the data
demonstrates a tendency toward a slightly higher expression of
ion transporters in Lcn2−/− mice than in WT mice this does
not offer an explanation for why WT mice are less efficient in
restraining infection at 3 weeks. Indeed, the increased transcript
levels of 24p3-R and 2,5-DHBA could reflect an compensatory
upregulation in the Lcn2-deficient mice at 3 weeks.
Neutrophils Co-localize With M.tb Early in
Infection
As neutrophil-derived lipocalin-2 was responsible for the
increased susceptibility inWTmice at 3 weeks post-challenge, we
speculated whether this could be explained by closer proximity
of neutrophils and mycobacteria at week 3. Histopathological
evaluation of lungs revealed that there were no major differences
in the structure and histological features between WT and
Lcn2−/− mice at 3 and 5 weeks, respectively. At 3 weeks
post-challenge the granulomas were loosely structured and
the inflammatory cells, primarily epithelioid macrophages,
lymphocytes, and neutrophil granulocytes, were scattered within
the granuloma in close proximity to the mycobacteria. In
contrast, at 5 weeks, granulomas were consolidated with a
well-organized and confluent outer structure. Mycobacteria
were primarily found within the granuloma surrounded by
multinucleated giant cells whereas neutrophils were outside the
granulomas (Figure 8). Evaluation of neutrophil presence within
the granulomas showed increased numbers of neutrophils within
the granuloma at 3 weeks compared to 5 weeks. At 5 weeks, only
few neutrophils were present, and lymphocytes dominated the
cellular rim that encircled the epithelioid center containing the
mycobacteria. Granulomas were rather small at 3 weeks, but after
5 weeks they composed 25% or more of the lung tissue. At 5
weeks the presence of mycobacteria within the granuloma was
less compared to 3 weeks, indicating that the immune response
was controlling the infection (Table 1).
DISCUSSION
Previous studies have revealed the importance of lipocalin-2
in combating M.tb infection. It has been demonstrated that
lipocalin-2 inhibits growth of M.tb by sequestration of iron-
loaded siderophores in both in vitro and in vivo models (21–
23, 31, 32). Although the innate immune response is primarily
important at the early stages of infection, previous in vivo
tuberculosis studies have focused on the effect of lacking
lipocalin-2 at later stages of infection, when the adaptive immune
response dominates (33). As lipocalin-2 is an innate immune
protein, we found it important to assess its role in M.tb infection
at an early time point when formation of the granuloma is
incomplete and T-cell mediated immune response is in its early
beginning (34).
At 3 weeks post-infection, expression of Lcn2 mRNA peaked
in lungs and high amounts of lipocalin-2 were present in lungs
and plasma. Surprisingly, WT mice had significantly higher
bacterial load in lungs compared to Lcn2−/− mice at this early
time point. However, when comparing bacterial load in lungs
over time within the two genotypes, WT mice were capable of
controlling the infection with a significantly reduced bacterial
load at 5 weeks post-infection. Lcn2−/− mice, on the other hand,
showed comparable bacterial loads at 3 and 5 weeks indicating
inability of these mice to restrain the infection. These results
emphasize, for the first time, that lipocalin-2 can facilitate M.tb
growth at the early phase of bacterial infection.
In a study by Saiga et al. (21) it was found that Lcn-2 is
highly expressed in the lung 2 days after intra-tracheal M.tb
installation and thereafter decreased. In our early expression
setup (Figure 4), where chimeric KO/WT andWT/KOmice were
aerosol infected, we saw no expression of Lcn2 prior to day 14
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TABLE 1 | Semi-quantitative evaluation of lung sections from WT mice and Lcn2−/− mice 3 and 5 weeks after aerosol challenge.
Genotype Weeks post-
challenge
Granuloma
involvement
Neutrophil
infiltration in
granuloma
ZN positive
mycobacteria in
granuloma
Granuloma morphology
WT 3 weeks 1 ++ ++ Granulomas consist of epithelioid histocytes admixed with neutrophils and
lymphocytes. ZN positive mycobacteria are diffusely scattered within the
granuloma. The structure of the granuloma is loose without presence of
multinucleated giant cells.
1 ++ ++
1 ++ +
1 ++ ++
1 ++ ++
Lcn2−/− 3 weeks 1 ++ ++
1 +++ ++
1 +++ ++
1 + +
1 +++ +
WT 5 weeks 2 ++ + Large consolidated and confluent granulomas with a core of epithelioid
histocytes and multinucleated giant cells surrounded by a rim of
lymphocytes. Only few neutrophils are present. ZN positive mycobacteria
are primarily present within the multinucleated giant cells.
2 + +
3 + ++
3 + ++
2 + +
Lcn2−/− 5 weeks 2 + +
2 + +
1 + +
2 + +
2 + ++
Granuloma morphology evaluated in a blinded fashion by a trained pathologist. Degree of granuloma involvement of total lung section: 1: <25%, 2: 25-50%, 3: >50%. Presence of
neutrophils or Ziehl-Nielsen (ZN) positive mycobacteria within the granulomas: +: minor, ++: moderate, +++: substantial.
after infection and moreover no migration of neutrophils to the
lung tissue was observed at these early time points. Following a
transient increase of lung neutrophils the day after infection, a
major influx of neutrophils to lungs at 3 weeks post-infection
was observed also in another M.tb.-infection study (35). This
fits our observations, that no major influx of neutrophils takes
place before day 14 and supports that 3 weeks was the optimal
time point to evaluate the role of lipocalin-2 in innate control of
M.tb. The differences between the lipocalin-2 expression profiles
in our study and the study by Saiga et al. are likely related to the
use of very different infection models. In the Saiga study mice
were intratracheally infected with 1 × 106 CFU, leading to a
direct installation of a very high dose of bacteria into the lungs.
In contrast, we used the more physiological aerosol infection
model, where mice inhaled H37Rv-containing droplets, receiving
∼1,000 CFU into the lungs, a delivered dose 1,000-fold lower
than in the Saiga model. These differences in bacterial load would
likely elicit very different innate immune responses in the two
scenarios, emphasizing the importance of M.tb model designs.
Previous studies have shown that the importance of cellular
source for delivery of lipocalin-2 is dependent on where in
the body lipocalin-2 is required for combat of microorganisms
(21, 36, 37). In a colitis model, epithelia-derived lipocalin-
2 was shown to be the major contributor of protection
rather than neutrophil-derived lipocalin-2 (37). In a pneumonia
infection model with Klebsiella pneumoniae, lipocalin-2 from
both epithelium and neutrophils was equally important for
full protection against infection (14). Our chimeric animal
experiments revealed that only myeloid-derived lipocalin-2
promoted early M.tb infection. Furthermore, by analyzing
mRNA expression between the chimeric groups, we found that
macrophages did not contribute with any significant amount
of lipocalin-2. This indicates that lipocalin-2 derived primarily
from infiltrating neutrophils 3 weeks after infection promote
the growth of M.tb. Epithelial cells also produce a substantial
amount of lipocalin-2, but lipocalin-2 secreted from these cell
types does not appear to play a central role in control of
M.tb. infection. At 3 weeks post-infection the mycobacteria are
primarily located within the lung parenchyma thus rendering the
bacteria inaccessible for epithelia-secreted lipocalin-2.
In a study by Guglani et al. (22), using a low dose aerosol
M.tbmodel, they describe a new role for lipocalin-2 in promoting
neutrophil influx while also constraining lymphocyte infiltration
by regulating Cxcl9 expression. There was no evidence in
our study that lipocalin-2 regulates lymphocytic inflammation
early in infection, since gene expression of lymphocytic
chemoattractants (Cxcl9, Cxcl10, and Ccl5) was identical between
genotypes. Furthermore, flow cytometry analysis of recruited
T- and B-cells showed equal cell counts across the genotypes.
Neutrophil migration was also independent of lipocalin-2, given
that MPO levels and neutrophil count were the same in WT and
Lcn2−/− mice. However, the expression profiles of neutrophil
chemoattractant Cxcl2 were different between genotypes, as
Cxcl2 continued to be expressed in the Lcn2−/− mice but
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downregulated over time in WT mice. This probably reflects
that the latter mice at 5 weeks post-challenge could control the
bacterial infection and thus had a decreased need for further
neutrophil influx. Levels of pro-inflammatory cytokines and
chemokines showed a matching pattern of expression in the
chimeric mice, with higher cytokine/chemokine levels found to
be associated with higher bacterial loads in the lungs.
In both WT and Lcn2−/− mice a shift from a primarily
innate immune gene expression profile at 3 weeks to an adaptive
immune profile at 5 weeks was observed for the cytokine
data, consistent with the known kinetics of a delayed adaptive
immunity to aerosol infection (38, 39), supporting 3 weeks as the
optimal time point for evaluating an innate immune response in
our model. However, we could not identify any specific changes
in the overall immune response that could explain the association
between lipocalin-2 and increased susceptibility to M.tb.
In recent years, lipocalin-2 has emerged as an important
player in iron homeostasis (28) and we considered whether
the growth-promoting effect of lipocalin-2 early in M.tb
infection was related to iron metabolism. Indeed, dysregulation
of iron uptake in a β-2-microglobulin knockout mouse
increases susceptibility to M.tb. growth in macrophages (40).
Expression of the three macrophage plasma-membrane related
iron transporters; transferrin-R, ferroportin, and DMT1 were
only slightly upregulated compared to uninfected mice after M.tb
infection. Especially ferroportin was of interest, as overexpression
of this cellular iron exporter inhibits intra-macrophage growth
of M.tb (41). NRAMP1 is a metal transporter located in the late
endosomal and phagosomal membrane of macrophages whose
main function is to enhance iron eﬄux from the phagosome,
thereby restricting growth of intracellular pathogens, such as
M.tb (42). NRAMP1 was highly upregulated in our model, but
expression levels were comparable between the two genotypes.
Of interest, we found the two known receptors of lipocalin-2,
megalin and 24p3-R (29, 30), to be excessively downregulated in
both infected Lcn2−/− and WT mice. It has been proposed that
24p3R can regulate intracellular iron concentration. Holo-24p3
binds 24p3R and is internalized. Its bound iron is released within
the cell leading to increased intracellular iron levels (30). The
observed decrease in lipocalin-2-binding receptors in our model
could illustrate a host defensemechanism that constrains delivery
of iron intracellularly, in order to deprive iron from the bacteria.
We also observed a decrease in expression of the suggested
mammalian siderophore 2.5-DHBA (Bdh2) (43). It has been
described that endogenous siderophores can be hijacked by
bacteria in order to forage iron and enhance growth (44).
Bdh2−/− mice showed no increased susceptibility to M.tb in
a low dose infection model 150 days post-infection, however,
4 weeks post-infection Bdh2−/− mice had much lower lung
CFU compared to WT mice (44). It has been disputed that
2.5-DHBA can mediate lipocalin-2 dependent iron uptake (45),
while others have confirmed that 2.5-DHBA can bind lipocalin-
2, but the binding affinity is rather low (19). Another suggested
mechanism for uptake of lipocalin-2 is binding of iron-loaded
catechol by lipocalin-2 followed by megalin-mediated uptake
(46). Receptor-independent endocytosis of iron-loaded lipocalin-
2 has also been suggested as a mechanism for transport of
iron over the cell membrane (47). Together this supports our
assumption that early in infection, when innate immunity
dominates, M.tb is dependent on intracellular iron delivery
from siderophores (both bacterial-produced and mammalian
analogs) and lipocalin-2. Yet, their role changes with time
as inflammation becomes dominated by the adaptive immune
response.
Contrary to earlier beliefs, nascent granulomas promote
mycobacterial replication (48). Following exposure to
mycobacteria in the lung, macrophages engulf the bacteria
and migrate into lung interstitial tissue. Here the macrophages
settle and might eventually succumb to the bacterial infection
causing the cell to undergo apoptosis. This initiates formation
of immature granulomas by recruitment of uninfected
macrophages to the site of infection that phagocytose the
dead macrophages carrying intracellular mycobacteria. The
newly recruited macrophages thereby become infected allowing
further mycobacterial expansion (48). This process continues
until a mature granuloma with a structured outer layer has
formed, coinciding with the onset of the adaptive immune
response. In the same manner neutrophils migrate to the
immature granuloma and release their content of lipocalin-2,
which binds bacterial or mammalian siderophores loaded
with iron. We propose a model where infected macrophages
take up iron-loaded lipocalin-2 potentially by lipocalin-2
receptor-mediated uptake. Lipocalin-2:siderophore-bound
iron may not be delivered directly to the phagocytic vacuole
since in vitro studies have described that exogenously added
lipocalin-2 resides in endosome and do not co-localize with
the mycobacterial phagosome (23). Possible mechanisms for
release of iron within the cell could be proteolytic degradation of
lipocalin-2 following its uptake in the macrophage. Alternatively,
iron could be rendered accessible for the bacteria in the
macrophage following engulfment and degradation of infected
apoptotic macrophages.
The histopathological evaluation demonstrates close
proximity of neutrophils and mycobacteria at week 3, but
not at week 5, post-challenge. This fits a model where lipocalin-
2 at the early stages of infection inadvertently feeds the
macrophages with iron essential for mycobacterial growth
thus giving the bacteria an initial growth advantage. Following
formation of the mature granuloma this is no longer possible
as neutrophils are now excluded from direct contact with the
infected macrophages, and lipocalin-2 therefore instead exerts
an antimicrobial role by binding and clearance of extracellular
mycobacterial siderophores following the occasional release of
mycobacteria from the mature granulomas. The downregulation
of receptors for lipocalin-2 uptake (and production of the
mammalian siderophore) following mycobacterial infection
could indicate a potential cellular protection mechanism to avoid
lipocalin-2-mediated iron uptake in cells invaded by intracellular
pathogens.
There are some limitations related to this study. The early
effect of lipocalin-2 was only investigated in an H37Rv M.tb
infection model. We chose this strain for our experiments since
it is the most studied strain with regard to evaluating the role
of lipocalin-2 in M.tb infection and we wanted to be able
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to compare our results with the prior research in this field.
It would be of great interest to establish whether the growth
promoting effect of lipocalin-2 at the early stages of infection
also applies to more virulent clinical M.tb strains. The function
of lipocalin-2 in human tuberculosis is almost undescribed.
However, lipocalin-2 is described as a potential biomarker of
M.tb infection (49) and its importance in infection models with
other lung pathogens is well-described. Therefore, our findings
in the mouse-model emphasize the importance of illuminating
the role of lipocalin-2 in human tuberculosis. When studying
lipocalin-2 in human M.tb infection, it is important to keep in
mind that human and mouse lipocalin-2 are 85% homologous
with regard to amino acid composition and share the same cup-
like form with 8 antiparallel β-sheets forming the calyx (28).
Transcriptional regulation of lipocalin-2 regulation is however
slightly different between humans and mice. Lipocalin-2 is an
acute phase protein in mice but not in humans (9, 10), and
TNF-α can independently stimulate lipocalin-2 expression in
mice, which is not the case in humans (10, 50). Furthermore,
mice only produce lipocalin-2 in its monomeric form and it
is thus unable to form a heterodimer with MMP-9 (51). These
differences in protein structure and transcriptional regulation
may influence the biological properties of the protein and cause
functional differences between species. A first step could be to
establish the function of the human lipocalin-2 ortholog in M.tb
mouse models.
In conclusion, this study demonstrates a co-localization
of granulocytes and M.tb within the innate granuloma and
describes, for the first time, a growth promoting effect of
neutrophil-derived lipocalin-2 at the early stages of M.tb
infection. We hypothesize that neutrophils deliver lipocalin-2 to
mycobacteria-infected macrophages early in infection, thereby
increasing the availability of intracellular iron and consequently
facilitating mycobacterial growth.
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Supplementary Figure 1 | Neutrophil chimerism of transplanted mice included in
experiments. (A) Gating strategy for estimation of neutrophil chimerism in blood of
bone-marrow transplanted mice 7 weeks post-transplant. (B) Results presented
as the percent of donor derived neutrophils of total neutrophils in bone marrow
transplanted mice included in experiments. Data from WT/WT, WT/KO, and
KO/WT is presented. KO/KO mice were not tested for chimerism.
Supplementary Figure 2 | Immune histochemical staining targeting lipocalin-2 in
chimeric mice. Staining for lipocalin-2 of lungs from WT/WT, KO/KO, KO/WT, and
WT/KO mice 3 weeks post-challenge with H37Rv M.tb. Pictures illustrate
differential expression of lipocalin-2 in epithelial- and myeloid cells depending on
chimeric composition.
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